Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.714
+0.130 (22.23%)
At close: Apr 29, 2026, 4:00 PM EDT
0.700
-0.014 (-1.99%)
After-hours: Apr 29, 2026, 4:13 PM EDT
Scinai Immunotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 2 | 3 | 3 | 10 | 43 | |
| Market Cap Growth | 35.28% | -13.44% | 10.12% | -74.89% | -76.24% | 34.05% | |
| Enterprise Value | 3 | 9 | 3 | 16 | 19 | 55 | |
| Last Close Price | 0.58 | 0.71 | 3.35 | 5.95 | 29.60 | 235.00 | |
| PS Ratio | 1.55 | 1.88 | 4.34 | - | - | - | |
| PB Ratio | 0.82 | 0.31 | 0.29 | -0.57 | -5.86 | 44.22 | |
| P/TBV Ratio | 0.82 | 1.00 | 0.66 | - | - | 44.22 | |
| EV/Sales Ratio | 2.02 | 7.22 | 4.63 | - | - | - | |
| Debt / Equity Ratio | 0.28 | 0.28 | 0.21 | -4.50 | -12.24 | 29.52 | |
| Net Debt / Equity Ratio | 0.08 | 0.08 | 0.01 | -3.43 | -4.24 | 11.82 | |
| Net Debt / EBITDA Ratio | -0.10 | -0.10 | -0.02 | -1.71 | -0.71 | -1.12 | |
| Net Debt / FCF Ratio | -0.10 | -0.10 | -0.02 | -1.57 | -0.92 | -1.53 | |
| Asset Turnover | 0.11 | 0.11 | 0.04 | - | - | - | |
| Quick Ratio | 1.15 | 1.15 | 1.21 | 2.94 | 6.07 | 7.15 | |
| Current Ratio | 1.30 | 1.30 | 1.32 | 3.06 | 6.15 | 7.30 | |
| Return on Equity (ROE) | -91.89% | -91.89% | 177.37% | - | - | - | |
| Return on Assets (ROA) | -37.60% | -37.60% | -34.92% | -27.24% | -23.39% | -26.97% | |
| Return on Capital Employed (ROCE) | -75.10% | -75.10% | -74.20% | -61.90% | -44.70% | -36.70% | |
| Earnings Yield | -408.04% | -336.35% | 168.09% | -250.86% | -56.18% | -18.90% | |
| FCF Yield | -297.42% | -245.17% | -222.45% | -386.66% | -78.52% | -17.42% | |
| Buyback Yield / Dilution | -189.55% | -189.55% | -106.41% | -107.22% | -33.56% | -27.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.